Patents Assigned to Merial SAS
  • Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
    Patent number: 7833783
    Abstract: The cloning of a novel PCVII viral genome is described as is expression of proteins derived from the PCVII genome. These proteins can be used in vaccine compositions for the prevention and treatment of PCVII infections, as well as in diagnostic methods for determining the presence of PCVII infections in a vertebrate subject. Polynucleotides derived from the viral genome can be used as diagnostic primers and probes.
    Type: Grant
    Filed: July 12, 2006
    Date of Patent: November 16, 2010
    Assignee: Merial SAS
    Inventors: Deborah Haines, Gordon Allan, John Ellis, Brian Meehan, Edward Clark, Lori Hassard, John Harding, Catherine Elisabeth Charreyre, Gilles Emile Chappuis, Francis McNeilly, Li Wang, Lorne A. Babiuk, Andrew A. Potter, Philip Willson
  • Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
    Patent number: 7803613
    Abstract: The cloning of a novel PCVII viral genome is described as is expression of proteins derived from the PCVII genome. These proteins can be used in vaccine compositions for the prevention and treatment of PCVII infections, as well as in diagnostic methods for determining the presence of PCVII infections in a vertebrate subject. Polynucleotides derived from the viral genome can be used as diagnostic primers and probes.
    Type: Grant
    Filed: July 12, 2006
    Date of Patent: September 28, 2010
    Assignee: Merial SAS
    Inventors: Deborah Haines, Gordon Allan, John Ellis, Brian Meehan, Edward Clark, Lori Hassard, John Harding, Catherine Elisabeth Charreyre, Gilles Emile Chappuis, Francis McNeilly, Li Wang, Lorne A. Babiuk, Andrew A. Potter, Philip Willson
  • Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
    Patent number: 7803926
    Abstract: The cloning of a novel PCVII viral genome is described as is expression of proteins derived from the PCVII genome. These proteins can be used in vaccine compositions for the prevention and treatment of PCVII infections, as well as in diagnostic methods for determining the presence of PCVII infections in a vertebrate subject. Polynucleotides derived from the viral genome can be used as diagnostic primers and probes.
    Type: Grant
    Filed: September 15, 2006
    Date of Patent: September 28, 2010
    Assignee: Merial SAS
    Inventors: Deborah Haines, Gordon Allan, John Ellis, Brian Meehan, Edward Clark, Lori Hassard, John Harding, Catherine Elisabeth Charreyre, Gilles Emile Chappuis, Francis McNeilly, Li Wang, Lorne A. Babiuk, Andrew A. Potter, Philip Willson
  • Postweaning multisystemic wasting syndrome virus from pigs
    Patent number: 7741039
    Abstract: The cloning of a novel PCVII viral genome is described as is expression of proteins derived from the PCVII genome. These proteins can be used in vaccine compositions for the prevention and treatment of PCVII infections, as well as in diagnostic methods for determining the presence of PCVII infections in a vertebrate subject. Polynucleotides derived from the viral genome can be used as diagnostic primers and probes.
    Type: Grant
    Filed: June 26, 2006
    Date of Patent: June 22, 2010
    Assignee: Merial SAS
    Inventors: Li Wang, Lorne A. Babiuk, Andrew A. Potter, Philip Willson
  • Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
    Patent number: 7504206
    Abstract: The cloning of a novel PCVII viral genome is described as is expression of proteins derived from the PCVII genome. These proteins can be used in vaccine compositions for the prevention and treatment of PCVII infections, as well as in diagnostic methods for determining the presence of PCVII infections in a vertebrate subject. Polynucleotides derived from the viral genome can be used as diagnostic primers and probes.
    Type: Grant
    Filed: September 1, 2005
    Date of Patent: March 17, 2009
    Assignee: Merial SAS
    Inventors: Deborah Haines, Gordon Allan, John Ellis, Brian Meehan, Edward Clark, Lori Hassard, John Harding, Catherine Elisabeth Charreyre, Gilles Emile Chappuis, Francis McNeilly, Li Wang, Lorne A. Babiuk, Andrew A. Potter, Philip Willson
  • Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
    Patent number: 7211379
    Abstract: Provided is a method for reducing viral load of porcine circovirus type 2 (PCV-2) in a pig by inducing an immune response against PCV-2 through the administration of an immunogenic composition comprising a PCV-2 antigen. A preferred antigen is a vector containing a PCV-2 nucleotide sequence. In a particularly preferred embodiment, the PCV-2 nucleotide sequence is ORF4, ORF13, or ORF4 and ORF13. In some embodiments, the immunogenic composition includes one or more additional pig pathogens.
    Type: Grant
    Filed: February 17, 2004
    Date of Patent: May 1, 2007
    Assignee: Merial SAS
    Inventors: John Ellis, Gordon Moore Allan, Brian Meehan, Edward Clark, Deborah Haines, Lori Hassard, John Harding, Catherine Elisabeth Charreyre, Gilles Emile Chappuis, George Steve Krakowka, Jean-Christophe Francis Audonnet, Francis McNeilly
  • Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
    Patent number: 7192594
    Abstract: The cloning of a novel PCVII viral genome is described as is expression of proteins derived from the PCVII genome. These proteins can be used in vaccine compositions for the prevention and treatment of PCVII infections, as well as in diagnostic methods for determining the presence of PCVII infections in a vertebrate subject. Polynucleotides derived from the viral genome can be used as diagnostic primers and probes.
    Type: Grant
    Filed: September 2, 2003
    Date of Patent: March 20, 2007
    Assignees: Merial Limited, Merial SAS
    Inventors: Deborah Haines, Gordon Allan, John Ellis, Brian Meehan, Edward Clark, Lori Hassard, John Harding, Catherine Elisabeth Charreyre, Gilles Emile Chappuis, Francis McNeilly, Li Wang, Lorne A. Babiuk, Andrew A. Potter, Philip Willson
  • Postweaning multisystemic wasting syndrome virus from pigs
    Patent number: 7144698
    Abstract: The cloning of a novel PCVII viral genome is described as is expression of proteins derived from the PCVII genome. These proteins can be used in vaccine compositions for the prevention and treatment of PCVII infections, as well as in diagnostic methods for determining the presence of PCVII infections in a vertebrate subject. Polynucleotides derived from the viral genome can be used as diagnostic primers and probes.
    Type: Grant
    Filed: December 31, 2002
    Date of Patent: December 5, 2006
    Assignee: Merial SAS
    Inventors: Li Wang, Lorne A. Babiuk, Andrew A. Potter, Philip Willson
  • Porcine circoviruses, vaccines and diagnostic reagents
    Patent number: 7122192
    Abstract: The invention relates to new porcine circovirus strains isolated from pulmonary or ganglionic samples obtained from farms affected by the post-weaning multisystemic wasting syndrome (PMWS). It relates to purified preparations of these strains, conventional attenuated or inactivated vaccines, recombinant live vaccines, plasmid vaccines and subunit vaccines, as well as reagents and diagnostic methods. It also relates to the DNA fragments which can be used for the production of subunits in an in vitro expression vector or as sequences to be integrated into a virus or plasmid type in vivo expression vector.
    Type: Grant
    Filed: July 21, 2003
    Date of Patent: October 17, 2006
    Assignee: Merial SAS
    Inventors: Gordon Allan, Brian Meehan, Edward Clark, John Ellis, Deborah Haines, Lori Hassard, John Harding, Catherine Elisabeth Charreyre, Gilles Emile Chappuis, Francis McNeilly